| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |